Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) 3-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co 3-Year EBITDA Growth Rate?

Guizhou Bailing Group Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.09.

During the past 12 months, Guizhou Bailing Group Pharmaceutical Co's average EBITDA Per Share Growth Rate was -254.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Guizhou Bailing Group Pharmaceutical Co was 20.70% per year. The lowest was -22.80% per year. And the median was 15.70% per year.

Competitive Comparison of Guizhou Bailing Group Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Bailing Group Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guizhou Bailing Group Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Bailing Group Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Guizhou Bailing Group Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Guizhou Bailing Group Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Guizhou Bailing Group Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000

Website

http://www.gzbl.com

Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.

Executives

Jiang Wei	Director
Jiang Yong	Directors, executives
Chen Pei	Directors, executives
Kuang Xun Hua	Director
Niu Min	Directors, Directors, and Executives
Chen Zhi	Securities Affairs Representative
Zheng Rong	Executives
Li Qiang	Supervisors
Xia Wen	Supervisors
Wang Xiao Dong	Supervisors
Teng Chun Jie	Supervisors
Li Hui Fang	Supervisors
Zhang Jin Fen	Director
Cai Shou Xian	Executives

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Headlines

No Headlines